BioCatalystWatch
ACETWorkspace / ACET / OverviewCompany library
Price
Market cap
Next catalystExpected Q4 2026Prulacabtagene leucel — planned LN pivotal study · Regulatory meetingCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

ADI-212

PSMA

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

CD20

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

CD20

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

CD20

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

CD20

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

ADI-212

PSMA

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

PreINDP1P2P3FilingApproved

Partner / License out

GPC3

History / paused

NKG2D ligands

PreINDP1P2P3FilingApproved
prulacabtagene leucel

CD20

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ACET PR & News

ACET SEC archive